Current and future use of angiotensin II receptor blockers in patients with COVID-19

No scientific evidence for the negative influence of angiotensin II receptor blockers onto COVID-19 clinical course has been identified so far. Prescribing angiotensin II receptor blockers as COVID-19 pathogenetic therapy could only be considered within clinical trials. Patients who have been taking...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Kachestvennai͡a︡ klinicheskai͡a︡ praktika 2020-10 (4S), p.28-31
Hauptverfasser:	Matveev, A. V., Otdelenov, V. A., Sychev, D. A.
Format:	Artikel
Sprache:	eng ; rus
Schlagworte:	covid-19 блокаторы рецептора ангиотензина 2-го типа коронавирус
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	No scientific evidence for the negative influence of angiotensin II receptor blockers onto COVID-19 clinical course has been identified so far. Prescribing angiotensin II receptor blockers as COVID-19 pathogenetic therapy could only be considered within clinical trials. Patients who have been taking angiotensin II receptor blockers for approved indications should continue to do so.
ISSN:	2588-0519 2618-8473
DOI:	10.37489/2588-0519-2020-S4-28-31